Quetta [Pakistan], May 10 (ANI): The Baloch Liberation Army (BLA) has claimed responsibility for a series of coordinated attacks at 39 different locations across Balochistan.

Findings from HERTHENA-Lung02 showed that the key secondary endpoint of overall survival did not meet statistical significance. Daiichi Sankyo and Merck have voluntarily withdrawn the Biologics ...

Patritumab deruxtecan's BLA withdrawal was due to HERTHENA-Lung02 trial's unsatisfactory overall survival results, despite progression-free survival significance. The HERTHENA-Lung02 trial compared ...

FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date Omeros Corporation ...

Omeros Corporation (Nasdaq: OMER) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Application (BLA) for ...